Opko Health Inc Stock News

I have previously discussed my views of the coronavirus pandemic, which included the fact that many states opened too early and that greater testing was needed.

Wall Street analysts expect Opko Health Inc. (NASDAQ:OPK) to report ($0.07) earnings per share (EPS) for the current quarter, according to Zacks. Three analysts have issued estimates for Opko Health�

Is (OPK) Outperforming Other Medical Stocks This Year?

Investors need to pay close attention to OPKO Health (OPK) stock based on the movements in the options market lately.

SMi reports: SMi are pleased to inform you that Vera Brinks, Director Pharmaceutics from ProQR Therapeutics has confirmed her position as speaker

Opko Health Inc. (NASDAQ:OPK) has been assigned a consensus recommendation of “Buy” from the six brokerages that are currently covering the company, Marketbeat reports. One research analyst has ra

Israel stocks lower at close of trade; TA 35 down 0.48%

Which stock wins in a battle between a COVID-19 testing leader and the top contract manufacturer for COVID-19 vaccines?

Immunic is cleared to start a phase 2 trial of its IMU-838 in COVID-19. Soleno receives a setback. Opko records positive data for somatrogon.

Swiss National Bank grew its holdings in Opko Health Inc. (NASDAQ:OPK) by 9.6% in the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor